Portfolio company
Tagomics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology company develops a multiomic profiling platform to assist biopharma and diagnostic organisations with disease detection, drug development and therapy selection.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Biomodal
This company develops multiomics sequencing kits and software for life scientists and clinical developers to analyse genetic and epigenetic data from single DNA samples.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Romix Bio
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
Motley Bio
This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
